We could not find any results for: Make sure your spelling is correct or try broadening your search.
It looks like you aren't logged in.Click the button below to log in and view your recent history.
Already a member? Sign in
Interactive Brokers
Connect with traders and investors in our Follow Feed community.
Explore comprehensive options data and use advanced filters with Options Flow.
Organize and monitor your stock and asset watchlist with Monitor.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION...
OMB APPROVAL OMB Number:3235-0080 Expires: March 31, 2018 Estimated average...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...
AOXING PHARMACEUTICAL COMPANY, INC. 1098 Foster City Blvd., Suite 106-810 Foster City, CA 94404 September...
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE...
As filed with the Securities and Exchange Commission on September 26, 2017 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ F...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM...
United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q [...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20...
United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q/A (Amendmen...
United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads